Cardinal Health Pops To New High On J&J Heart Business Acquisition

Shares of Cardinal Health (CAH) were rising on Monday after briefly toughing a new 52-week high on news it will buy Johnson & Johnson’s (JNJ) heart product business. Cardinal said it would pay $1.94 billion in cash for Cordis, which makes cardiac stents and other medical devices, in a bid to broaden its product portfolio. [...]
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.